These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 19527717

  • 21. JNK1 is required to preserve cardiac function in the early response to pressure overload.
    Tachibana H, Perrino C, Takaoka H, Davis RJ, Naga Prasad SV, Rockman HA.
    Biochem Biophys Res Commun; 2006 May 19; 343(4):1060-6. PubMed ID: 16579967
    [Abstract] [Full Text] [Related]

  • 22. Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.
    Cubero FJ, Zoubek ME, Hu W, Peng J, Zhao G, Nevzorova YA, Al Masaoudi M, Bechmann LP, Boekschoten MV, Muller M, Preisinger C, Gassler N, Canbay AE, Luedde T, Davis RJ, Liedtke C, Trautwein C.
    Gastroenterology; 2016 Apr 19; 150(4):968-81. PubMed ID: 26708719
    [Abstract] [Full Text] [Related]

  • 23. Design and synthesis of 2'-anilino-4,4'-bipyridines as selective inhibitors of c-Jun N-terminal kinase-3.
    Swahn BM, Xue Y, Arzel E, Kallin E, Magnus A, Plobeck N, Viklund J.
    Bioorg Med Chem Lett; 2006 Mar 01; 16(5):1397-401. PubMed ID: 16337120
    [Abstract] [Full Text] [Related]

  • 24. JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells.
    Yan F, Wang XM, Liu ZC, Pan C, Yuan SB, Ma QM.
    Hepatobiliary Pancreat Dis Int; 2010 Jun 01; 9(3):287-95. PubMed ID: 20525557
    [Abstract] [Full Text] [Related]

  • 25. 1-Aryl-3,4-dihydroisoquinoline inhibitors of JNK3.
    Christopher JA, Atkinson FL, Bax BD, Brown MJ, Champigny AC, Chuang TT, Jones EJ, Mosley JE, Musgrave JR.
    Bioorg Med Chem Lett; 2009 Apr 15; 19(8):2230-4. PubMed ID: 19303774
    [Abstract] [Full Text] [Related]

  • 26. JNK1 is not essential for TNF-mediated joint disease.
    Köller M, Hayer S, Redlich K, Ricci R, David JP, Steiner G, Smolen JS, Wagner EF, Schett G.
    Arthritis Res Ther; 2005 Apr 15; 7(1):R166-73. PubMed ID: 15642137
    [Abstract] [Full Text] [Related]

  • 27. Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.
    Alam M, Beevers RE, Ceska T, Davenport RJ, Dickson KM, Fortunato M, Gowers L, Haughan AF, James LA, Jones MW, Kinsella N, Lowe C, Meissner JW, Nicolas AL, Perry BG, Phillips DJ, Pitt WR, Platt A, Ratcliffe AJ, Sharpe A, Tait LJ.
    Bioorg Med Chem Lett; 2007 Jun 15; 17(12):3463-7. PubMed ID: 17459703
    [Abstract] [Full Text] [Related]

  • 28. JNK1 protects against glucolipotoxicity-mediated beta-cell apoptosis.
    Prause M, Christensen DP, Billestrup N, Mandrup-Poulsen T.
    PLoS One; 2014 Jun 15; 9(1):e87067. PubMed ID: 24475223
    [Abstract] [Full Text] [Related]

  • 29. c-Jun N-terminal kinase regulates CTP:phosphocholine cytidylyltransferase.
    Ryan AJ, Andrews M, Zhou J, Mallampalli RK.
    Arch Biochem Biophys; 2006 Mar 01; 447(1):23-33. PubMed ID: 16466687
    [Abstract] [Full Text] [Related]

  • 30. N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.
    Angell RM, Atkinson FL, Brown MJ, Chuang TT, Christopher JA, Cichy-Knight M, Dunn AK, Hightower KE, Malkakorpi S, Musgrave JR, Neu M, Rowland P, Shea RL, Smith JL, Somers DO, Thomas SA, Thompson G, Wang R.
    Bioorg Med Chem Lett; 2007 Mar 01; 17(5):1296-301. PubMed ID: 17194588
    [Abstract] [Full Text] [Related]

  • 31. Sodium hydrogen exchange 1 (NHE-1) regulates connexin 43 expression in cardiomyocytes via reverse mode sodium calcium exchange and c-Jun NH2-terminal kinase-dependent pathways.
    Stanbouly S, Kirshenbaum LA, Jones DL, Karmazyn M.
    J Pharmacol Exp Ther; 2008 Oct 01; 327(1):105-13. PubMed ID: 18650245
    [Abstract] [Full Text] [Related]

  • 32. Isoform-specific functions of c-Jun N-terminal kinase 1 and 2 in lung ischemia-reperfusion injury through the c-Jun/activator protein-1 pathway.
    Tan J, Gao W, Yang W, Zeng X, Wang L, Cui X.
    J Thorac Cardiovasc Surg; 2021 Aug 01; 162(2):e143-e156. PubMed ID: 32414595
    [Abstract] [Full Text] [Related]

  • 33. Structural basis and biological consequences for JNK2/3 isoform selective aminopyrazoles.
    Park H, Iqbal S, Hernandez P, Mora R, Zheng K, Feng Y, LoGrasso P.
    Sci Rep; 2015 Jan 27; 5():8047. PubMed ID: 25623238
    [Abstract] [Full Text] [Related]

  • 34. Distinct roles of c-Jun N-terminal kinase isoforms in neurite initiation and elongation during axonal regeneration.
    Barnat M, Enslen H, Propst F, Davis RJ, Soares S, Nothias F.
    J Neurosci; 2010 Jun 09; 30(23):7804-16. PubMed ID: 20534829
    [Abstract] [Full Text] [Related]

  • 35. Knockout of c-Jun N-terminal kinases 1, 2 or 3 isoforms induces behavioural changes.
    Reinecke K, Herdegen T, Eminel S, Aldenhoff JB, Schiffelholz T.
    Behav Brain Res; 2013 May 15; 245():88-95. PubMed ID: 23428746
    [Abstract] [Full Text] [Related]

  • 36. JNK3 maintains expression of the insulin receptor substrate 2 (IRS2) in insulin-secreting cells: functional consequences for insulin signaling.
    Abdelli S, Bonny C.
    PLoS One; 2012 May 15; 7(5):e35997. PubMed ID: 22563476
    [Abstract] [Full Text] [Related]

  • 37. Biological evaluation and structural determinants of p38α mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids.
    Goettert M, Schattel V, Koch P, Merfort I, Laufer S.
    Chembiochem; 2010 Dec 10; 11(18):2579-88. PubMed ID: 21108268
    [Abstract] [Full Text] [Related]

  • 38. c-Jun N-terminal kinase 1 phosphorylates Myt1 to prevent UVA-induced skin cancer.
    Choi HS, Bode AM, Shim JH, Lee SY, Dong Z.
    Mol Cell Biol; 2009 Apr 10; 29(8):2168-80. PubMed ID: 19204086
    [Abstract] [Full Text] [Related]

  • 39. Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK.
    Hom RK, Bowers S, Sealy JM, Truong AP, Probst GD, Neitzel ML, Neitz RJ, Fang L, Brogley L, Wu J, Konradi AW, Sham HL, Tóth G, Pan H, Yao N, Artis DR, Quinn K, Sauer JM, Powell K, Ren Z, Bard F, Yednock TA, Griswold-Prenner I.
    Bioorg Med Chem Lett; 2010 Dec 15; 20(24):7303-7. PubMed ID: 21071223
    [Abstract] [Full Text] [Related]

  • 40. Activity of all JNK isoforms contributes to neurite growth in spiral ganglion neurons.
    Atkinson PJ, Cho CH, Hansen MR, Green SH.
    Hear Res; 2011 Aug 15; 278(1-2):77-85. PubMed ID: 21554942
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.